BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 21301969)

  • 1. Magnetic resonance imaging and ultrasonography in predicting infiltrating residual disease after preoperative chemotherapy in stage II-III breast cancer.
    Guarneri V; Pecchi A; Piacentini F; Barbieri E; Dieci MV; Ficarra G; Tazzioli G; Frassoldati A; Battista R; Canossi B; Mauri C; D'Amico R; Conte P; Torricelli P
    Ann Surg Oncol; 2011 Aug; 18(8):2150-7. PubMed ID: 21301969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI staging after neoadjuvant chemotherapy for breast cancer: does tumor biology affect accuracy?
    McGuire KP; Toro-Burguete J; Dang H; Young J; Soran A; Zuley M; Bhargava R; Bonaventura M; Johnson R; Ahrendt G
    Ann Surg Oncol; 2011 Oct; 18(11):3149-54. PubMed ID: 21947592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative evaluation of residual tumor extent by three-dimensional magnetic resonance imaging in breast cancer patients treated with neoadjuvant chemotherapy.
    Akazawa K; Tamaki Y; Taguchi T; Tanji Y; Miyoshi Y; Kim SJ; Ueda S; Yanagisawa T; Sato Y; Tamura S; Noguchi S
    Breast J; 2006; 12(2):130-7. PubMed ID: 16509837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of dynamic magnetic resonance imaging in the evaluation of tumor response to preoperative concurrent radiochemotherapy for large breast cancers: a prospective phase II study.
    Bollet MA; Thibault F; Bouillon K; Meunier M; Sigal-Zafrani B; Savignoni A; Diéras V; Nos C; Salmon R; Fourquet A;
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):13-8. PubMed ID: 17449193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients.
    Croshaw R; Shapiro-Wright H; Svensson E; Erb K; Julian T
    Ann Surg Oncol; 2011 Oct; 18(11):3160-3. PubMed ID: 21947594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer.
    Escobar PF; Patrick RJ; Rybicki LA; Hicks D; Weng DE; Crowe JP
    Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI versus ultrasonography and mammography for preoperative assessment of breast cancer.
    Wasif N; Garreau J; Terando A; Kirsch D; Mund DF; Giuliano AE
    Am Surg; 2009 Oct; 75(10):970-5. PubMed ID: 19886147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging.
    Bedrosian I; Mick R; Orel SG; Schnall M; Reynolds C; Spitz FR; Callans LS; Buzby GP; Rosato EF; Fraker DL; Czerniecki BJ
    Cancer; 2003 Aug; 98(3):468-73. PubMed ID: 12879462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting nipple-areolar involvement using preoperative breast MRI and primary tumor characteristics.
    Steen ST; Chung AP; Han SH; Vinstein AL; Yoon JL; Giuliano AE
    Ann Surg Oncol; 2013 Feb; 20(2):633-9. PubMed ID: 22965571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic enhanced MRI predicts chemosensitivity in breast cancer patients.
    Nagashima T; Sakakibara M; Nakamura R; Arai M; Kadowaki M; Kazama T; Nakatani Y; Koda K; Miyazaki M
    Eur J Radiol; 2006 Nov; 60(2):270-4. PubMed ID: 16926079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy.
    Hwang N; Schiller DE; Crystal P; Maki E; McCready DR
    Ann Surg Oncol; 2009 Nov; 16(11):3000-9. PubMed ID: 19603233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging evaluation of residual ductal carcinoma in situ following preoperative chemotherapy in breast cancer patients.
    Choi HK; Cho N; Moon WK; Im SA; Han W; Noh DY
    Eur J Radiol; 2012 Apr; 81(4):737-43. PubMed ID: 21300498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MRI evaluation of primary chemotherapy response in breast cancer].
    Vénat-Bouvet L; Desfougères M; Aubard Y; Mollard J; Fermeaux V; Genet D; Labourey JL; Martin J; Lebrun-Ly V; Maubon A; Tubiana-Mathieu N
    Bull Cancer; 2004 Sep; 91(9):721-8. PubMed ID: 15544998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
    Shen J; Gilcrease MZ; Babiera GV; Ross MI; Meric-Bernstam F; Feig BW; Kuerer HM; Francis A; Ames FC; Hunt KK
    Cancer; 2007 Apr; 109(7):1255-63. PubMed ID: 17330229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative taxane-based chemotherapy in a standardized protocol for locally advanced breast cancer.
    Chan A; Willsher PC; Hastrich DJ; Anderson J; Barham T; Latham B; Redfern A; VAN DER Schaaf A; Thomson J; Joseph D; Ingram D
    Asia Pac J Clin Oncol; 2012 Mar; 8(1):62-70. PubMed ID: 22369445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1062-73. PubMed ID: 15234040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor reduction rate predicts early recurrence in patients with breast cancer failing to achieve complete response to primary chemotherapy.
    Nagashima T; Sakakibara M; Sangai T; Kazama T; Nakatani Y; Miyazaki M
    Breast Cancer; 2010 Apr; 17(2):125-30. PubMed ID: 19459030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordance between pathologic and radiologic tumor size on breast MRI may contribute to increased re-excision rates.
    Vanderwalde LH; Dang CM; Bresee C; Phillips EH
    Am Surg; 2011 Oct; 77(10):1361-3. PubMed ID: 22127089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI for surgical planning in patients with breast cancer who undergo preoperative chemotherapy.
    Thibault F; Nos C; Meunier M; El Khoury C; Ollivier L; Sigal-Zafrani B; Clough K;
    AJR Am J Roentgenol; 2004 Oct; 183(4):1159-68. PubMed ID: 15385323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.